Excessive lipid availability induces insulin resistance in the liver, which manifests as the inability of insulin to suppress hepatic gluconeogenesis and glucose release in the circulation, thus contributing to fasting hyperglycemia and eventually type 2 diabetes (242). The gene discussed is INS; the disease is type 2 diabetes mellitus.